ReNetX adds Dr. Kevin Malobisky to SAB
ReNetX Bio has added Dr. Kevin Malobisky to its Scientific Advisory Board. Dr. Malobisky, currently the Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics, brings over...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
ReNetX Bio has added Dr. Kevin Malobisky to its Scientific Advisory Board. Dr. Malobisky, currently the Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics, brings over...
Shoreline Biome was recently awarded a patent for the “Combined Lysis Protocol for Comprehensive Cell Lysis.” The patent outlines the method and materials for the lysis of...
Pharmaceutical company Cara Therapeutics is expanding its Stamford headquarters by 11,685 square feet. more
Last June, Guilford-based Bioasis struck an agreement to license it s xB3 platform technology to the research giant Chiesi Group for the development of drugs...
Yale Engage, in conjunction with the Yale Cancer Center, presents the Yale Engage Cancer Series, an interactive webinar series, promoting impactful collaboration between academic experts...
BioCT invites your nominations for the 2020 Entrepreneur of the Year Award. The Entrepreneur of the Year Award was established by BioCT and Shipman and...
The days of operating in stealth mode may well be over for the MedTech scene in the Greater New Haven Hub! It continues to rise...
Executives at health care information firm Sema4 believe their business is “well positioned” after recently raising $121 million in new funding and achieving an overall valuation of...
Alexion reports that the Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorization in the European Union for a...
Boehringer Ingelheim has received fast track designation from the FDA for the development of Jardiance (empagliflozin) to prevent hospitalization for heart failure and reduce the risk...